Mesoblast Limited - American Depositary Shares (MESO) analyst actions
Rating and price-target actions on MESO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MESO overview →
1 measured MESO analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD | Press release | +0.00% | +0.91% |
Keep exploring
More MESO: earnings → · SEC filings → · MESO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mirati Therapeutics, Inc. (MRTX) | 109 | +0.11% | 81% |
| Avinger, Inc. (AVGR) | 108 | -0.24% | 29% |
| WELLNESS CENTER USA INC (WCUI) | 108 | 0.00% | 24% |
| BAYER AG S/ADR (BAYRY) | 106 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.